Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | March 21, 2011 | ||||
| Last Updated Date | June 20, 2012 | ||||
| Start Date ICMJE | June 2009 | ||||
| Primary Completion Date | May 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Accuracy and Interrater Reliability of HRME Image Interpretation [ Time Frame: baseline ] [ Designated as safety issue: No ] We will ask blinded raters to classify the HRME images as either benign (normal) or dysplastic/cancerous (abnormal) |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01321892 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium | ||||
| Official Title ICMJE | Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium | ||||
| Brief Summary | The purpose of this research study is to collect information on whether images made using investigational microscopes can improve researchers' ability to evaluate and distinguish between normal and abnormal areas in tissue samples surgically removed from patients with squamous cell carcinoma. The microscopes being used in this study are considered investigational because they have not been approved by the United States Food and Drug Administration (FDA) for finding abnormal or pre-cancerous areas. |
||||
| Detailed Description | The overall objective of this exploratory study is to evaluate whether noninvasive fluorescence and reflectance imaging of the upper aerodigestive tract can help clinicians more accurately determine intraoperative margins during ablative cancer surgery. This is an ex vivo study designed to evaluate the feasibility of using prototype optical imaging technology to enhance the discrimination between areas of noncancerous "normal" and cancerous mucosa. The results of this laboratory study will be used to further refine and develop this technology for in vivo application. Primary Aim: (1) To collect data to develop imaging algorithms to distinguish between normal and cancerous upper aerodigestive mucosa. Secondary Aims:
|
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Cross-Sectional |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples Without DNA Description: Retained specimens are punch biopsy specimens from the primary tumor resection. |
||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Patients with new head and neck cancer, who reside in the tri-state area. |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Squamous cell carcinoma
Patients included in this study will be receiving surgical treatment for their biopsy-proven squamous cell carcinoma. |
||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 64 | ||||
| Completion Date | May 2012 | ||||
| Primary Completion Date | May 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria: • Presence of medical or psychiatric condition affecting ability to give voluntary, informed consent. |
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01321892 | ||||
| Other Study ID Numbers ICMJE | GCO # 09-0945 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Mount Sinai School of Medicine | ||||
| Study Sponsor ICMJE | Mount Sinai School of Medicine | ||||
| Collaborators ICMJE | William Marsh Rice University | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Mount Sinai School of Medicine | ||||
| Verification Date | June 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||